O	O	O	0	6	Cobalt	Cobalt	B-NP	NN	O	2	NMOD	O
O	O	O	7	15	chloride	chloride	I-NP	NN	O	5	NMOD	O
O	O	O	15	16	-	-	B-NP	HYPH	O	2	P	O
O	O	O	16	23	induced	induce	I-NP	VBN	O	5	NMOD	O
O	O	O	24	33	signaling	signaling	I-NP	NN	O	29	SUB	O
O	O	O	34	36	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	37	48	endothelium	endothelium	B-NP	NN	O	6	PMOD	O
O	O	O	49	56	leading	lead	B-VP	VBG	O	7	NMOD	O
O	O	O	57	59	to	to	B-PP	TO	O	8	VMOD	O
O	O	O	60	63	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	64	73	augmented	augmented	I-NP	JJ	O	12	NMOD	O
O	O	O	74	83	adherence	adherence	I-NP	NN	O	20	NMOD	O
O	O	O	84	86	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	87	93	sickle	sickle	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	94	97	red	red	I-NP	JJ	I-cell_type	17	NMOD	I-cell_type
O	O	O	98	103	blood	blood	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	O	104	109	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	O	110	113	and	and	O	CC	O	20	NMOD	O
O	O	O	114	130	transendothelial	transendothelial	B-NP	JJ	O	20	NMOD	O
O	O	O	131	140	migration	migration	I-NP	NN	O	9	PMOD	O
O	O	O	141	143	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	144	152	monocyte	monocyte	B-NP	NN	B-cell_line	28	NMOD	B-cell_line
O	O	O	152	153	-	-	O	HYPH	I-cell_line	28	NMOD	I-cell_line
O	O	O	153	157	like	like	B-NP	JJ	I-cell_line	28	NMOD	I-cell_line
O	O	O	158	160	HL	HL	I-NP	NN	I-cell_line	28	NMOD	I-cell_line
O	O	O	160	161	-	-	O	HYPH	I-cell_line	28	NMOD	I-cell_line
O	O	O	161	163	60	60	B-NP	CD	I-cell_line	28	NMOD	I-cell_line
O	O	O	164	169	cells	cell	I-NP	NNS	I-cell_line	21	PMOD	I-cell_line
O	O	O	170	172	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	173	180	blocked	block	I-VP	VBN	O	29	VC	O
O	O	O	181	183	by	by	B-PP	IN	O	30	VMOD	O
T1	B-Protein	B-Protein	184	187	PAF	PAF	B-NP	NN	B-protein	35	NMOD	B-protein
T1	I-Protein	I-Protein	187	188	-	-	I-NP	HYPH	O	35	NMOD	O
T1	I-Protein	I-Protein	188	196	receptor	receptor	I-NP	NN	O	35	NMOD	O
O	O	O	197	207	antagonist	antagonist	I-NP	NN	O	31	PMOD	O
O	O	O	207	208	.	.	O	.	O	29	P	O

O	O	O	210	212	In	In	B-PP	IN	O	16	VMOD	O
O	O	O	213	221	response	response	B-NP	NN	O	1	PMOD	O
O	O	O	222	224	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	225	232	hypoxia	hypoxia	B-NP	NN	O	9	NMOD	O
O	O	O	232	233	,	,	O	,	O	9	P	O
O	O	O	234	240	sickle	sickle	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	241	244	red	red	I-NP	JJ	I-cell_type	9	NMOD	I-cell_type
O	O	O	245	250	blood	blood	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	O	251	256	cells	cell	I-NP	NNS	I-cell_type	15	NMOD	I-cell_type
O	O	O	257	258	(	(	O	(	O	13	DEP	O
O	O	O	258	260	SS	SS	B-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	O	261	264	RBC	RBC	I-NP	NN	I-cell_type	13	DEP	I-cell_type
O	O	O	264	265	)	)	O	)	O	9	NMOD	O
O	O	O	266	269	and	and	O	CC	O	15	NMOD	O
O	O	O	270	280	leukocytes	leukocyte	B-NP	NNS	B-cell_type	3	PMOD	B-cell_type
O	O	O	281	288	exhibit	exhibit	B-VP	VBP	O	0	ROOT	O
O	O	O	289	298	increased	increase	B-NP	VBN	O	18	NMOD	O
O	O	O	299	308	adherence	adherence	I-NP	NN	O	16	OBJ	O
O	O	O	309	311	to	to	B-PP	TO	O	18	NMOD	O
O	O	O	312	315	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	316	324	vascular	vascular	I-NP	JJ	O	22	NMOD	O
O	O	O	325	336	endothelium	endothelium	I-NP	NN	O	19	PMOD	O
O	O	O	336	337	,	,	O	,	O	16	P	O
O	O	O	338	343	while	while	B-SBAR	IN	O	16	VMOD	O
O	O	O	344	354	diapedesis	diapedesis	B-NP	NN	O	32	SUB	O
O	O	O	355	357	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	358	368	leukocytes	leukocyte	B-NP	NNS	B-cell_type	26	PMOD	B-cell_type
O	O	O	369	376	through	through	B-PP	IN	O	25	NMOD	O
O	O	O	377	380	the	the	B-NP	DT	O	31	NMOD	O
O	O	O	381	386	blood	blood	I-NP	NN	O	31	NMOD	O
O	O	O	387	393	vessel	vessel	I-NP	NN	O	28	PMOD	O
O	O	O	394	403	increases	increase	I-NP	NNS	O	24	SBAR	O
O	O	O	403	404	.	.	O	.	O	16	P	O

O	O	O	405	412	However	However	B-ADVP	RB	O	13	VMOD	O
O	O	O	412	413	,	,	O	,	O	13	P	O
O	O	O	414	417	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	418	426	cellular	cellular	I-NP	JJ	O	8	NMOD	O
O	O	O	427	436	signaling	signaling	I-NP	NN	O	8	NMOD	O
O	O	O	437	444	pathway	pathway	I-NP	NN	O	8	NMOD	O
O	O	O	444	445	(	(	I-NP	(	O	8	NMOD	O
O	O	O	445	446	s	s	I-NP	NNS	O	13	SUB	O
O	O	O	446	447	)	)	O	)	O	8	NMOD	O
O	O	O	448	454	caused	cause	B-VP	VBN	O	8	NMOD	O
O	O	O	455	457	by	by	B-PP	IN	O	10	VMOD	O
O	O	O	458	465	hypoxia	hypoxia	B-NP	NN	O	11	PMOD	O
O	O	O	466	468	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	469	475	poorly	poorly	B-ADJP	RB	O	13	VMOD	O
O	O	O	476	486	understood	understand	I-ADJP	VBN	O	13	VC	O
O	O	O	486	487	.	.	O	.	O	13	P	O

O	O	O	488	490	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	491	499	utilized	utilize	B-VP	VBD	O	0	ROOT	O
O	O	O	500	505	CoCl2	CoCl2	B-NP	NN	O	2	OBJ	O
O	O	O	506	508	as	as	B-PP	IN	O	2	VMOD	O
O	O	O	509	510	a	a	B-NP	DT	O	7	NMOD	O
O	O	O	511	518	mimetic	mimetic	I-NP	JJ	O	7	NMOD	O
O	O	O	519	527	molecule	molecule	I-NP	NN	O	4	PMOD	O
O	O	O	528	531	for	for	B-PP	IN	O	7	NMOD	O
O	O	O	532	539	hypoxia	hypoxia	B-NP	NN	O	8	PMOD	O
O	O	O	540	542	to	to	B-VP	TO	O	11	VMOD	O
O	O	O	543	548	study	study	I-VP	VB	O	2	VMOD	O
O	O	O	549	557	cellular	cellular	B-NP	JJ	O	14	NMOD	O
O	O	O	558	567	signaling	signaling	I-NP	NN	O	14	NMOD	O
O	O	O	568	576	pathways	pathway	I-NP	NNS	O	11	OBJ	O
O	O	O	576	577	.	.	O	.	O	2	P	O

O	O	O	578	580	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	581	586	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	587	591	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	592	594	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	595	600	human	human	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	601	610	umbilical	umbilical	I-NP	JJ	I-cell_type	9	NMOD	I-cell_type
O	O	O	611	615	vein	vein	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	O	616	627	endothelial	endothelial	I-NP	JJ	I-cell_type	9	NMOD	I-cell_type
O	O	O	628	633	cells	cell	I-NP	NNS	I-cell_type	4	PMOD	I-cell_type
O	O	O	634	635	(	(	O	(	O	12	DEP	O
O	O	O	635	640	HUVEC	HUVEC	B-NP	NNS	B-cell_line	12	DEP	B-cell_line
O	O	O	640	641	)	)	O	)	O	9	NMOD	O
O	O	O	641	642	,	,	O	,	O	19	P	O
O	O	O	643	648	CoCl2	CoCl2	B-NP	NN	O	19	SUB	O
O	O	O	649	651	at	at	B-PP	IN	O	14	NMOD	O
O	O	O	652	653	2	2	B-NP	CD	O	17	AMOD	O
O	O	O	654	656	mM	mM	I-NP	NN	O	18	NMOD	O
O	O	O	657	670	concentration	concentration	I-NP	NN	O	15	PMOD	O
O	O	O	671	678	induced	induce	B-VP	VBD	O	3	SBAR	O
O	O	O	679	682	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	683	690	surface	surface	I-NP	NN	O	22	NMOD	O
O	O	O	691	701	expression	expression	I-NP	NN	O	34	NMOD	O
O	O	O	702	704	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	705	706	a	a	B-NP	DT	O	25	NMOD	O
O	O	O	707	713	subset	subset	I-NP	NN	O	23	PMOD	O
O	O	O	714	716	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	717	721	CAMs	CAM	B-NP	NNS	B-protein	26	PMOD	B-protein
O	O	O	722	723	(	(	O	(	O	32	DEP	O
T2	B-Protein	B-Protein	723	727	VCAM	VCAM	B-NP	NN	B-protein	30	NMOD	B-protein
T2	I-Protein	I-Protein	727	728	-	-	B-NP	HYPH	I-protein	32	DEP	I-protein
T2	I-Protein	I-Protein	728	729	1	1	I-NP	CD	I-protein	30	NMOD	I-protein
O	O	O	729	730	)	)	O	)	O	25	NMOD	O
O	O	O	731	734	and	and	O	CC	O	34	NMOD	O
O	O	O	735	745	activation	activation	B-NP	NN	O	19	OBJ	O
O	O	O	746	748	of	of	B-PP	IN	O	34	NMOD	O
T15	B-Entity	B-Entity	749	762	transcription	transcription	B-NP	NN	B-protein	37	NMOD	B-protein
T15	I-Entity	I-Entity	763	769	factor	factor	I-NP	NN	I-protein	40	NMOD	I-protein
T15	I-Entity	I-Entity	770	772	NF	NF	I-NP	NN	B-protein	40	NMOD	B-protein
T15	I-Entity	I-Entity	772	773	-	-	B-NP	HYPH	I-protein	40	NMOD	I-protein
T15	I-Entity	I-Entity	773	779	kappaB	kappaB	I-NP	NN	I-protein	35	PMOD	I-protein
O	O	O	780	782	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	783	786	the	the	B-NP	DT	O	44	NMOD	O
O	O	O	787	794	nuclear	nuclear	I-NP	JJ	O	44	NMOD	O
O	O	O	795	803	extracts	extract	I-NP	NNS	O	41	PMOD	O
O	O	O	804	806	of	of	B-PP	IN	O	44	NMOD	O
O	O	O	807	812	HUVEC	HUVEC	B-NP	NN	B-cell_line	45	PMOD	B-cell_line
O	O	O	812	813	.	.	O	.	O	2	P	O

O	O	O	814	825	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD	O
O	O	O	825	826	,	,	O	,	O	5	P	O
O	O	O	827	832	CoCl2	CoCl2	B-NP	NN	O	5	SUB	O
O	O	O	833	837	also	also	B-ADVP	RB	O	5	VMOD	O
O	O	O	838	844	caused	cause	B-VP	VBD	O	0	ROOT	O
O	O	O	845	849	time	time	B-NP	NN	O	10	NMOD	O
O	O	O	849	850	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	O	850	859	dependent	dependent	I-NP	JJ	O	10	NMOD	O
T16	B-Entity	B-Entity	860	868	tyrosine	tyrosine	I-NP	NN	O	10	NMOD	O
O	O	O	869	884	phosphorylation	phosphorylation	I-NP	NN	O	5	OBJ	O
O	O	O	885	887	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	888	895	mitogen	mitogen	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	895	896	-	-	O	HYPH	I-protein	21	P	I-protein
O	O	O	896	905	activated	activate	B-NP	VBN	I-protein	21	NMOD	I-protein
O	O	O	906	913	protein	protein	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	914	915	(	(	O	(	I-protein	21	NMOD	I-protein
O	O	O	915	918	MAP	MAP	B-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	918	919	)	)	O	)	I-protein	21	NMOD	I-protein
O	O	O	920	926	kinase	kinase	B-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	927	934	isoform	isoform	I-NP	NN	O	21	NMOD	O
T3	B-Protein	B-Protein	935	939	ERK2	ERK2	I-NP	NN	B-protein	11	PMOD	B-protein
O	O	O	940	947	without	without	B-PP	IN	O	5	VMOD	O
O	O	O	948	961	significantly	significantly	B-VP	RB	O	24	VMOD	O
O	O	O	962	971	affecting	affect	I-VP	VBG	O	22	PMOD	O
T4	B-Protein	B-Protein	972	976	ERK1	ERK1	B-NP	NN	B-protein	24	OBJ	B-protein
O	O	O	976	977	,	,	O	,	O	5	P	O
O	O	O	978	988	indicating	indicate	B-VP	VBG	O	5	VMOD	O
T5	B-Protein	B-Protein	989	993	ERK2	ERK2	B-NP	NN	B-protein	29	SUB	B-protein
O	O	O	994	996	is	be	B-VP	VBZ	O	27	VMOD	O
O	O	O	997	1000	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	1001	1010	preferred	prefer	I-NP	VBN	O	32	NMOD	O
O	O	O	1011	1020	substrate	substrate	I-NP	NN	O	29	PRD	O
O	O	O	1021	1024	for	for	B-PP	IN	O	32	NMOD	O
O	O	O	1025	1033	upstream	upstream	B-NP	JJ	B-protein	35	NMOD	B-protein
O	O	O	1034	1040	kinase	kinase	I-NP	NN	I-protein	33	PMOD	I-protein
O	O	O	1041	1043	of	of	B-PP	IN	O	35	NMOD	O
O	O	O	1044	1047	the	the	B-NP	DT	O	39	NMOD	O
O	O	O	1048	1052	MAPK	MAPK	I-NP	NN	B-protein	39	NMOD	B-protein
O	O	O	1053	1060	pathway	pathway	I-NP	NN	O	36	PMOD	O
O	O	O	1060	1061	.	.	O	.	O	5	P	O

O	O	O	1062	1072	Inhibitors	Inhibitor	B-NP	NNS	O	22	SUB	O
O	O	O	1073	1075	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1076	1079	MAP	MAP	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	1080	1086	kinase	kinase	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	1087	1088	(	(	O	(	O	7	DEP	O
O	O	O	1088	1095	PD98059	PD98059	B-NP	NN	O	7	DEP	O
O	O	O	1095	1096	)	)	O	)	O	4	NMOD	O
O	O	O	1097	1099	or	or	O	CC	O	12	NMOD	O
O	O	O	1100	1108	platelet	platelet	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	1108	1109	-	-	O	HYPH	I-protein	12	NMOD	I-protein
O	O	O	1109	1119	activating	activate	B-VP	VBG	I-protein	12	NMOD	I-protein
O	O	O	1120	1126	factor	factor	B-NP	NN	I-protein	4	NMOD	I-protein
O	O	O	1127	1128	(	(	O	(	O	15	DEP	O
O	O	O	1128	1131	PAF	PAF	B-NP	NN	B-protein	15	DEP	B-protein
O	O	O	1131	1132	)	)	O	)	O	12	NMOD	O
O	O	O	1132	1133	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	O	1134	1142	receptor	receptor	I-NP	NN	O	18	NMOD	O
O	O	O	1143	1153	antagonist	antagonist	I-NP	NN	O	2	PMOD	O
O	O	O	1154	1155	(	(	O	(	O	21	DEP	O
O	O	O	1155	1161	CV3988	CV3988	B-NP	NN	O	21	DEP	O
O	O	O	1161	1162	)	)	O	)	O	18	NMOD	O
O	O	O	1163	1172	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	1173	1176	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	1177	1182	CoCl2	CoCl2	I-NP	NN	O	35	NMOD	O
O	O	O	1182	1183	-	-	B-VP	HYPH	O	35	P	O
O	O	O	1183	1190	induced	induce	B-NP	VBN	O	35	NMOD	O
T17	B-Entity	B-Entity	1191	1193	NF	NF	I-NP	NN	B-protein	29	NMOD	B-protein
T17	I-Entity	I-Entity	1193	1194	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
T17	I-Entity	I-Entity	1194	1200	kappaB	kappaB	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	1201	1211	activation	activation	I-NP	NN	O	35	NMOD	O
O	O	O	1212	1215	and	and	O	CC	O	35	NMOD	O
T6	B-Protein	B-Protein	1216	1220	VCAM	VCAM	B-NP	NN	B-protein	35	NMOD	B-protein
T6	I-Protein	I-Protein	1220	1221	-	-	O	HYPH	I-protein	35	NMOD	I-protein
T6	I-Protein	I-Protein	1221	1222	1	1	B-NP	CD	I-protein	35	NMOD	I-protein
O	O	O	1223	1233	expression	expression	I-NP	NN	O	22	OBJ	O
O	O	O	1233	1234	.	.	O	.	O	22	P	O

O	O	O	1235	1244	Augmented	Augmented	B-NP	JJ	O	2	NMOD	O
O	O	O	1245	1255	expression	expression	I-NP	NN	O	7	SUB	O
O	O	O	1256	1258	of	of	B-PP	IN	O	2	NMOD	O
T7	B-Protein	B-Protein	1259	1263	VCAM	VCAM	B-NP	NN	B-protein	5	NMOD	B-protein
T7	I-Protein	I-Protein	1263	1264	-	-	B-NP	HYPH	I-protein	3	PMOD	I-protein
T7	I-Protein	I-Protein	1264	1265	1	1	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	O	1266	1269	led	lead	B-VP	VBD	O	0	ROOT	O
O	O	O	1270	1272	to	to	B-PP	TO	O	7	VMOD	O
O	O	O	1273	1282	increased	increase	B-NP	VBN	O	12	NMOD	O
O	O	O	1283	1285	SS	SS	I-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	O	1286	1289	RBC	RBC	I-NP	NN	I-cell_type	12	NMOD	I-cell_type
O	O	O	1290	1298	adhesion	adhesion	I-NP	NN	O	8	PMOD	O
O	O	O	1298	1299	,	,	O	,	O	12	P	O
O	O	O	1300	1311	inhibitable	inhibitable	B-ADJP	JJ	O	12	NMOD	O
O	O	O	1312	1314	by	by	B-PP	IN	O	14	AMOD	O
O	O	O	1315	1316	a	a	B-NP	DT	O	20	NMOD	O
T8	B-Protein	B-Protein	1317	1321	VCAM	VCAM	I-NP	NN	B-protein	20	NMOD	B-protein
T8	I-Protein	I-Protein	1321	1322	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T8	I-Protein	I-Protein	1322	1323	1	1	I-NP	CD	I-protein	20	NMOD	I-protein
O	O	O	1324	1332	antibody	antibody	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	O	1332	1333	.	.	O	.	O	7	P	O

O	O	O	1334	1346	Additionally	Additionally	B-ADVP	RB	O	4	VMOD	O
O	O	O	1346	1347	,	,	O	,	O	4	P	O
O	O	O	1348	1353	CoCl2	CoCl2	B-NP	NN	O	4	SUB	O
O	O	O	1354	1360	caused	cause	B-VP	VBD	O	0	ROOT	O
O	O	O	1361	1362	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	1363	1366	two	two	I-NP	CD	O	10	NMOD	O
O	O	O	1366	1367	-	-	B-ADVP	HYPH	O	6	P	O
O	O	O	1368	1370	to	to	B-PP	TO	O	9	AMOD	O
O	O	O	1371	1380	threefold	threefold	B-NP	JJ	O	6	NMOD	O
O	O	O	1381	1389	increase	increase	I-NP	NN	O	28	NMOD	O
O	O	O	1390	1392	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	1393	1396	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1397	1401	rate	rate	I-NP	NN	O	11	PMOD	O
O	O	O	1402	1404	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	1405	1421	transendothelial	transendothelial	B-NP	JJ	O	16	NMOD	O
O	O	O	1422	1431	migration	migration	I-NP	NN	O	14	PMOD	O
O	O	O	1432	1434	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1435	1443	monocyte	monocyte	B-NP	NN	B-cell_line	24	NMOD	B-cell_line
O	O	O	1443	1444	-	-	O	HYPH	I-cell_line	24	NMOD	I-cell_line
O	O	O	1444	1448	like	like	B-NP	JJ	I-cell_line	24	NMOD	I-cell_line
O	O	O	1449	1451	HL	HL	I-NP	NN	I-cell_line	24	NMOD	I-cell_line
O	O	O	1451	1452	-	-	O	HYPH	I-cell_line	24	NMOD	I-cell_line
O	O	O	1452	1454	60	60	B-NP	CD	I-cell_line	24	NMOD	I-cell_line
O	O	O	1455	1460	cells	cell	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	O	1461	1464	and	and	O	CC	O	28	NMOD	O
O	O	O	1465	1466	a	a	B-NP	DT	O	28	NMOD	O
O	O	O	1467	1477	twentyfold	twentyfold	I-NP	JJ	O	28	NMOD	O
O	O	O	1478	1486	increase	increase	I-NP	NN	O	4	OBJ	O
O	O	O	1487	1489	in	in	B-PP	IN	O	28	NMOD	O
O	O	O	1490	1505	phosphorylation	phosphorylation	B-NP	NN	O	29	PMOD	O
O	O	O	1506	1508	of	of	B-PP	IN	O	30	NMOD	O
O	O	O	1509	1517	platelet	platelet	B-NP	NN	B-protein	36	NMOD	B-protein
O	O	O	1518	1529	endothelial	endothelial	I-NP	JJ	I-protein	36	NMOD	I-protein
O	O	O	1530	1534	cell	cell	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	O	1535	1543	adhesion	adhesion	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	O	1544	1553	molecules	molecule	I-NP	NNS	I-protein	31	PMOD	I-protein
O	O	O	1554	1555	(	(	O	(	O	41	DEP	O
T9	B-Protein	B-Protein	1555	1560	PECAM	PECAM	B-NP	NN	B-protein	39	NMOD	B-protein
T9	I-Protein	I-Protein	1560	1561	-	-	B-NP	HYPH	I-protein	41	DEP	I-protein
T9	I-Protein	I-Protein	1561	1562	1	1	I-NP	CD	I-protein	39	NMOD	I-protein
O	O	O	1562	1563	)	)	O	)	O	36	NMOD	O
O	O	O	1563	1564	.	.	O	.	O	4	P	O

O	O	O	1565	1568	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1569	1585	transendothelial	transendothelial	I-NP	JJ	O	3	NMOD	O
O	O	O	1586	1595	migration	migration	I-NP	NN	O	6	SUB	O
O	O	O	1596	1598	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	1599	1608	monocytes	monocyte	B-NP	NNS	B-cell_type	4	PMOD	B-cell_type
O	O	O	1609	1612	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1613	1622	inhibited	inhibit	I-VP	VBN	O	6	VC	O
O	O	O	1623	1625	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	1626	1628	an	an	B-NP	DT	O	10	NMOD	O
O	O	O	1629	1637	antibody	antibody	I-NP	NN	O	8	PMOD	O
O	O	O	1638	1640	to	to	B-PP	TO	O	10	NMOD	O
T10	B-Protein	B-Protein	1641	1646	PECAM	PECAM	B-NP	NN	B-protein	13	NMOD	B-protein
T10	I-Protein	I-Protein	1646	1647	-	-	B-NP	HYPH	I-protein	11	PMOD	I-protein
T10	I-Protein	I-Protein	1647	1648	1	1	I-NP	CD	I-protein	13	NMOD	I-protein
O	O	O	1648	1649	.	.	O	.	O	6	P	O

O	O	O	1650	1654	Both	Both	O	CC	O	2	NMOD	O
O	O	O	1655	1670	phosphorylation	phosphorylation	B-NP	NN	O	16	SUB	O
O	O	O	1671	1673	of	of	B-PP	IN	O	2	NMOD	O
T11	B-Protein	B-Protein	1674	1679	PECAM	PECAM	B-NP	NN	B-protein	5	NMOD	B-protein
T11	I-Protein	I-Protein	1679	1680	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T11	I-Protein	I-Protein	1680	1681	1	1	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	O	1682	1685	and	and	O	CC	O	5	NMOD	O
O	O	O	1686	1702	transendothelial	transendothelial	B-NP	JJ	O	9	NMOD	O
O	O	O	1703	1712	migration	migration	I-NP	NN	O	3	PMOD	O
O	O	O	1713	1715	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1716	1725	monocytes	monocyte	B-NP	NNS	B-cell_type	10	PMOD	B-cell_type
O	O	O	1726	1728	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	1729	1737	response	response	B-NP	NN	O	12	PMOD	O
O	O	O	1738	1740	to	to	B-PP	TO	O	13	NMOD	O
O	O	O	1741	1746	CoCl2	CoCl2	B-NP	NN	O	14	PMOD	O
O	O	O	1747	1751	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1752	1761	inhibited	inhibit	I-VP	VBN	O	16	VC	O
O	O	O	1762	1764	by	by	B-PP	IN	O	17	VMOD	O
O	O	O	1765	1772	protein	protein	B-NP	NN	O	21	NMOD	O
O	O	O	1773	1779	kinase	kinase	I-NP	NN	O	21	NMOD	O
O	O	O	1780	1789	inhibitor	inhibitor	I-NP	NN	O	18	PMOD	O
O	O	O	1790	1791	(	(	O	(	O	24	DEP	O
O	O	O	1791	1800	GF109203X	GF109203X	B-NP	NN	O	24	DEP	O
O	O	O	1800	1801	)	)	O	)	O	21	NMOD	O
O	O	O	1802	1805	and	and	O	CC	O	17	VMOD	O
O	O	O	1806	1815	augmented	augment	B-VP	VBN	O	17	VMOD	O
O	O	O	1816	1818	by	by	B-PP	IN	O	26	VMOD	O
O	O	O	1819	1826	protein	protein	B-NP	NN	O	30	NMOD	O
O	O	O	1827	1838	phosphatase	phosphatase	I-NP	NN	O	30	NMOD	O
O	O	O	1839	1848	inhibitor	inhibitor	I-NP	NN	O	27	PMOD	O
O	O	O	1849	1850	(	(	O	(	O	34	DEP	O
O	O	O	1850	1859	Calyculin	Calyculin	B-NP	NN	B-protein	33	NMOD	B-protein
O	O	O	1860	1861	A	A	I-NP	NN	I-protein	34	DEP	I-protein
O	O	O	1861	1862	)	)	O	)	O	30	NMOD	O
O	O	O	1862	1863	.	.	O	.	O	16	P	O

O	O	O	1864	1867	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1868	1872	data	datum	I-NP	NNS	O	3	SUB	O
O	O	O	1873	1881	suggests	suggest	B-VP	VBZ	O	0	ROOT	O
O	O	O	1882	1886	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1887	1892	CoCl2	CoCl2	B-NP	NN	O	19	SUB	O
O	O	O	1892	1893	-	-	O	HYPH	O	19	P	O
O	O	O	1893	1900	induced	induce	B-NP	VBN	O	9	NMOD	O
O	O	O	1901	1909	cellular	cellular	I-NP	JJ	O	9	NMOD	O
O	O	O	1910	1917	signals	signal	I-NP	NNS	O	19	SUB	O
O	O	O	1918	1927	directing	direct	B-VP	VBG	O	9	NMOD	O
O	O	O	1928	1937	increased	increase	B-NP	VBN	O	12	NMOD	O
O	O	O	1938	1948	expression	expression	I-NP	NN	O	10	OBJ	O
O	O	O	1949	1951	of	of	B-PP	IN	O	12	NMOD	O
T12	B-Protein	B-Protein	1952	1956	VCAM	VCAM	B-NP	NN	B-protein	15	NMOD	B-protein
T12	I-Protein	I-Protein	1956	1957	-	-	B-NP	HYPH	I-protein	13	PMOD	I-protein
T12	I-Protein	I-Protein	1957	1958	1	1	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	O	1959	1961	in	in	B-PP	IN	O	12	NMOD	O
O	O	O	1962	1967	HUVEC	HUVEC	B-NP	NN	B-cell_type	17	PMOD	B-cell_type
O	O	O	1968	1975	involve	involve	B-VP	VBP	O	4	SBAR	O
O	O	O	1976	1986	downstream	downstream	B-NP	JJ	O	21	NMOD	O
O	O	O	1987	1997	activation	activation	I-NP	NN	O	19	OBJ	O
O	O	O	1998	2000	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	2001	2004	MAP	MAP	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	2005	2011	kinase	kinase	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	O	2012	2015	and	and	I-NP	CC	O	28	NMOD	O
T18	B-Entity	B-Entity	2016	2018	NF	NF	I-NP	NN	B-protein	28	NMOD	B-protein
T18	I-Entity	I-Entity	2018	2019	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T18	I-Entity	I-Entity	2019	2025	kappaB	kappaB	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	O	2025	2026	,	,	O	,	O	19	P	O
O	O	O	2027	2032	while	while	B-SBAR	IN	O	19	VMOD	O
O	O	O	2033	2036	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	2037	2052	phosphorylation	phosphorylation	I-NP	NN	O	37	SUB	O
O	O	O	2053	2055	of	of	B-PP	IN	O	32	NMOD	O
T13	B-Protein	B-Protein	2056	2061	PECAM	PECAM	B-NP	NN	B-protein	35	NMOD	B-protein
T13	I-Protein	I-Protein	2061	2062	-	-	B-NP	HYPH	I-protein	33	PMOD	I-protein
T13	I-Protein	I-Protein	2062	2063	1	1	I-NP	CD	I-protein	35	NMOD	I-protein
O	O	O	2064	2070	occurs	occur	B-VP	VBZ	O	30	SBAR	O
O	O	O	2071	2073	as	as	B-PP	IN	O	37	VMOD	O
O	O	O	2074	2075	a	a	B-NP	DT	O	40	NMOD	O
O	O	O	2076	2082	result	result	I-NP	NN	O	38	PMOD	O
O	O	O	2083	2085	of	of	B-PP	IN	O	40	NMOD	O
O	O	O	2086	2096	activation	activation	B-NP	NN	O	41	PMOD	O
O	O	O	2097	2099	of	of	B-PP	IN	O	42	NMOD	O
O	O	O	2100	2103	PKC	PKC	B-NP	NN	B-protein	43	PMOD	B-protein
O	O	O	2103	2104	.	.	O	.	O	3	P	O

O	O	O	2105	2107	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	2108	2116	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	O	2117	2121	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	2122	2125	PAF	PAF	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	2125	2126	-	-	B-NP	HYPH	O	7	NMOD	O
O	O	O	2126	2134	receptor	receptor	I-NP	NN	O	7	NMOD	O
O	O	O	2135	2145	antagonist	antagonist	I-NP	NN	O	8	SUB	O
O	O	O	2146	2154	inhibits	inhibit	B-VP	VBZ	O	3	SBAR	O
O	O	O	2155	2158	the	the	B-NP	DT	O	8	OBJ	O
O	O	O	2159	2164	CoCl2	CoCl2	I-NP	NN	O	9	DEP	O
O	O	O	2164	2165	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	O	2166	2168	or	or	I-NP	CC	O	11	PMOD	O
O	O	O	2169	2176	hypoxia	hypoxia	I-NP	NN	O	12	PMOD	O
O	O	O	2176	2177	-	-	O	HYPH	O	13	NMOD	O
O	O	O	2177	2184	induced	induce	B-NP	VBN	O	16	NMOD	O
O	O	O	2185	2193	increase	increase	I-NP	NN	O	33	NMOD	O
O	O	O	2194	2196	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	2197	2200	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	2201	2209	adhesion	adhesion	I-NP	NN	O	17	PMOD	O
O	O	O	2210	2212	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	2213	2215	SS	SS	B-NP	NN	B-cell_type	22	NMOD	B-cell_type
O	O	O	2216	2219	RBC	RBC	I-NP	NN	I-cell_type	20	PMOD	I-cell_type
O	O	O	2219	2220	,	,	O	,	O	33	P	O
T14	B-Protein	B-Protein	2221	2226	PECAM	PECAM	B-NP	NN	B-protein	27	NMOD	B-protein
T14	I-Protein	I-Protein	2226	2227	-	-	B-NP	HYPH	O	27	NMOD	O
T14	I-Protein	I-Protein	2227	2228	1	1	I-NP	CD	O	27	NMOD	O
O	O	O	2229	2244	phosphorylation	phosphorylation	I-NP	NN	O	33	NMOD	O
O	O	O	2244	2245	,	,	O	,	O	33	P	O
O	O	O	2246	2249	and	and	O	CC	O	33	NMOD	O
O	O	O	2250	2253	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	2254	2265	concomitant	concomitant	I-NP	JJ	O	33	NMOD	O
O	O	O	2266	2282	transendothelial	transendothelial	I-NP	JJ	O	33	NMOD	O
O	O	O	2283	2292	migration	migration	I-NP	NN	O	14	PMOD	O
O	O	O	2293	2295	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	2296	2305	monocytes	monocyte	B-NP	NNS	B-cell_type	34	PMOD	B-cell_type
O	O	O	2305	2306	.	.	O	.	O	2	P	O
